Stocksigma LogoStocksigma Logo

Thyrocare Divests Radiology Subsidiary Nueclear Healthcare for Rs 141.40 Crore

Thyrocare Technologies approved divesting 100% of its wholly owned subsidiary Nueclear Healthcare Limited (NHL) to Trovera Healthcare for ~Rs 141.40 cr to

Thyrocare Divests Radiology Subsidiary Nueclear Healthcare for Rs 141.40 Crore

Thyrocare Technologies Ltd 路 Others (Uncategorized) 路 21 Sept 2026, 8:36 pm

Thyrocare Divests Radiology Subsidiary Nueclear Healthcare for Rs 141.40 Crore Thyrocare Technologies approved divesting 100% of its wholly owned subsidiary Nueclear Healthcare Limited (NHL) to Trovera Healthcare for ~Rs 141.40 cr to focus on core pathology. The consideration comprises Rs 81.90 cr in cash (subject to working capital adjustments) and Rs 59.50 cr via 42,500 CCPS of Trovera (~4.5% fully diluted stake). Simultaneously, Thyrocare will acquire NHL's Gurugram and Hyderabad lab properties for Rs 20.59 cr. NHL contributed Rs 44.62 cr (5.38%) to FY26 consolidated revenue. The transaction expects completion by 30th Nov'26, subject to shareholder approval.

Original exchange filing (PDF)

More announcements from Thyrocare Technologies Ltd

All Thyrocare Technologies Ltd announcements